vs
Astrana Health, Inc.（ASTH）とEncompass Health Corp（EHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $950.5M、Astrana Health, Inc.の約1.6倍）。Encompass Health Corpの純利益率が高く（9.5% vs 0.7%、差は8.8%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 9.9%）。Encompass Health Corpの直近四半期フリーキャッシュフローが多い（$116.7M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 8.3%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
ASTH vs EHC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $1.5B |
| 純利益 | $6.6M | $146.1M |
| 粗利率 | — | — |
| 営業利益率 | 1.9% | 16.7% |
| 純利益率 | 0.7% | 9.5% |
| 売上前年比 | 42.9% | 9.9% |
| 純利益前年比 | 184.4% | 20.8% |
| EPS（希薄化後） | $0.12 | $1.43 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $1.5B | ||
| Q3 25 | $956.0M | $1.5B | ||
| Q2 25 | $654.8M | $1.5B | ||
| Q1 25 | $620.4M | $1.5B | ||
| Q4 24 | $665.2M | $1.4B | ||
| Q3 24 | $478.7M | $1.4B | ||
| Q2 24 | $486.3M | $1.3B | ||
| Q1 24 | $404.4M | $1.3B |
| Q4 25 | $6.6M | $146.1M | ||
| Q3 25 | $373.0K | $126.5M | ||
| Q2 25 | $9.4M | $142.1M | ||
| Q1 25 | $6.7M | $151.5M | ||
| Q4 24 | $-7.8M | $120.9M | ||
| Q3 24 | $16.1M | $108.2M | ||
| Q2 24 | $19.2M | $114.1M | ||
| Q1 24 | $14.8M | $112.5M |
| Q4 25 | 1.9% | 16.7% | ||
| Q3 25 | 2.0% | 14.9% | ||
| Q2 25 | 3.1% | 16.2% | ||
| Q1 25 | 3.3% | 16.4% | ||
| Q4 24 | 0.1% | 14.3% | ||
| Q3 24 | 5.9% | 13.6% | ||
| Q2 24 | 6.2% | 14.3% | ||
| Q1 24 | 7.5% | 13.6% |
| Q4 25 | 0.7% | 9.5% | ||
| Q3 25 | 0.0% | 8.6% | ||
| Q2 25 | 1.4% | 9.7% | ||
| Q1 25 | 1.1% | 10.4% | ||
| Q4 24 | -1.2% | 8.6% | ||
| Q3 24 | 3.4% | 8.0% | ||
| Q2 24 | 3.9% | 8.8% | ||
| Q1 24 | 3.7% | 8.5% |
| Q4 25 | $0.12 | $1.43 | ||
| Q3 25 | $0.01 | $1.24 | ||
| Q2 25 | $0.19 | $1.39 | ||
| Q1 25 | $0.14 | $1.48 | ||
| Q4 24 | $-0.14 | $1.18 | ||
| Q3 24 | $0.33 | $1.06 | ||
| Q2 24 | $0.40 | $1.12 | ||
| Q1 24 | $0.31 | $1.10 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $72.2M |
| 総負債低いほど良い | — | $2.4B |
| 株主資本純資産 | $779.3M | $2.4B |
| 総資産 | $2.2B | $7.1B |
| 負債/資本比率低いほどレバレッジが低い | — | 1.00× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $72.2M | ||
| Q3 25 | $463.4M | $48.7M | ||
| Q2 25 | $342.1M | $99.1M | ||
| Q1 25 | $260.9M | $95.8M | ||
| Q4 24 | $290.8M | $85.4M | ||
| Q3 24 | $350.3M | $147.8M | ||
| Q2 24 | $327.7M | $154.4M | ||
| Q1 24 | $337.3M | $134.4M |
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | — | $2.7B | ||
| Q1 24 | — | $2.7B |
| Q4 25 | $779.3M | $2.4B | ||
| Q3 25 | $775.5M | $2.4B | ||
| Q2 25 | $765.5M | $2.3B | ||
| Q1 25 | $745.4M | $2.2B | ||
| Q4 24 | $712.7M | $2.1B | ||
| Q3 24 | $704.6M | $2.0B | ||
| Q2 24 | $678.9M | $1.8B | ||
| Q1 24 | $653.5M | $1.7B |
| Q4 25 | $2.2B | $7.1B | ||
| Q3 25 | $2.2B | $6.9B | ||
| Q2 25 | $1.4B | $6.8B | ||
| Q1 25 | $1.3B | $6.6B | ||
| Q4 24 | $1.4B | $6.5B | ||
| Q3 24 | $1.3B | $6.5B | ||
| Q2 24 | $1.3B | $6.4B | ||
| Q1 24 | $1.2B | $6.2B |
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.01× | ||
| Q2 25 | — | 1.02× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.14× | ||
| Q3 24 | — | 1.20× | ||
| Q2 24 | — | 1.46× | ||
| Q1 24 | — | 1.54× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $346.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $116.7M |
| FCFマージンFCF / 売上 | -0.6% | 7.6% |
| 設備投資強度設備投資 / 売上 | 0.3% | 14.8% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 2.37× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $439.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $346.0M | ||
| Q3 25 | $10.0M | $270.8M | ||
| Q2 25 | $90.9M | $270.2M | ||
| Q1 25 | $16.6M | $288.6M | ||
| Q4 24 | $-10.9M | $278.8M | ||
| Q3 24 | $34.0M | $267.8M | ||
| Q2 24 | $23.2M | $217.4M | ||
| Q1 24 | $6.0M | $238.8M |
| Q4 25 | $-6.0M | $116.7M | ||
| Q3 25 | $7.4M | $83.7M | ||
| Q2 25 | $89.5M | $113.3M | ||
| Q1 25 | $13.6M | $125.5M | ||
| Q4 24 | $-13.5M | $80.1M | ||
| Q3 24 | $31.7M | $120.3M | ||
| Q2 24 | $20.4M | $60.5M | ||
| Q1 24 | $5.6M | $99.4M |
| Q4 25 | -0.6% | 7.6% | ||
| Q3 25 | 0.8% | 5.7% | ||
| Q2 25 | 13.7% | 7.8% | ||
| Q1 25 | 2.2% | 8.6% | ||
| Q4 24 | -2.0% | 5.7% | ||
| Q3 24 | 6.6% | 8.9% | ||
| Q2 24 | 4.2% | 4.6% | ||
| Q1 24 | 1.4% | 7.6% |
| Q4 25 | 0.3% | 14.8% | ||
| Q3 25 | 0.3% | 12.7% | ||
| Q2 25 | 0.2% | 10.8% | ||
| Q1 25 | 0.5% | 11.2% | ||
| Q4 24 | 0.4% | 14.1% | ||
| Q3 24 | 0.5% | 10.9% | ||
| Q2 24 | 0.6% | 12.1% | ||
| Q1 24 | 0.1% | 10.6% |
| Q4 25 | -0.44× | 2.37× | ||
| Q3 25 | 26.69× | 2.14× | ||
| Q2 25 | 9.65× | 1.90× | ||
| Q1 25 | 2.48× | 1.90× | ||
| Q4 24 | — | 2.31× | ||
| Q3 24 | 2.11× | 2.48× | ||
| Q2 24 | 1.21× | 1.91× | ||
| Q1 24 | 0.40× | 2.12× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
